Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Love

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease riskScott Miners, Zoë van Helmond, Rachel Barker, et al.
Brain : a Journal of Neurology|December 24, 2016
Reply: Atherosclerosis and vascular cognitive impairment neuropathological guidelineOlivia A Skrobot, Johannes Attems, Margaret Esiri, et al.
Human Mutation|March 17, 2004
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolismHagit Katzov, Katy Chalmers, Juni Palmgren, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2016
A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative CohortOlivia Anna Skrobot, Amy Jayne McKnight, Peter Anthony Passmore, et al.
Antioxidants & Redox Signaling|October 8, 2013
The branched-chain aminotransferase proteins: novel redox chaperones for protein disulfide isomerase--implications in Alzheimer's diseaseMaya El Hindy, Mohammed Hezwani, David Corry, et al.
Nature Communications|August 22, 2022
Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathologyLasse Pihlstrøm, Gemma Shireby, Hanneke Geut, et al.
Nature Communications|September 24, 2022
DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-typesGemma Shireby, Emma L Dempster, Stefania Policicchio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2016
The Vascular Impairment of Cognition Classification Consensus StudyOlivia A Skrobot, John O'Brien, Sandra Black, et al.
Brain : a Journal of Neurology|December 10, 2020
Recalibrating the epigenetic clock: implications for assessing biological age in the human cortexGemma L Shireby, Jonathan P Davies, Paul T Francis, et al.
Molecular Neurodegeneration|August 27, 2015
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationAoife P Kiely, Helen Ling, Yasmine T Asi, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease riskScott Miners, Zoë van Helmond, Rachel Barker, et al.
Brain : a Journal of Neurology|December 24, 2016
Reply: Atherosclerosis and vascular cognitive impairment neuropathological guidelineOlivia A Skrobot, Johannes Attems, Margaret Esiri, et al.
Human Mutation|March 17, 2004
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolismHagit Katzov, Katy Chalmers, Juni Palmgren, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2016
A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative CohortOlivia Anna Skrobot, Amy Jayne McKnight, Peter Anthony Passmore, et al.
Antioxidants & Redox Signaling|October 8, 2013
The branched-chain aminotransferase proteins: novel redox chaperones for protein disulfide isomerase--implications in Alzheimer's diseaseMaya El Hindy, Mohammed Hezwani, David Corry, et al.
Nature Communications|August 22, 2022
Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathologyLasse Pihlstrøm, Gemma Shireby, Hanneke Geut, et al.
Nature Communications|September 24, 2022
DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-typesGemma Shireby, Emma L Dempster, Stefania Policicchio, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 14, 2016
The Vascular Impairment of Cognition Classification Consensus StudyOlivia A Skrobot, John O'Brien, Sandra Black, et al.
Brain : a Journal of Neurology|December 10, 2020
Recalibrating the epigenetic clock: implications for assessing biological age in the human cortexGemma L Shireby, Jonathan P Davies, Paul T Francis, et al.
Molecular Neurodegeneration|August 27, 2015
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationAoife P Kiely, Helen Ling, Yasmine T Asi, et al.
Pageof 21